ClinicalTrials.gg
Drug

Gimeracil clinical trials

studies test it
183
open now
26
in phase 3
30
first study started
2001

How each study uses gimeracil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the gimeracil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
14 Mar 2011 · Teysuno · EMEA/H/C/001242 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

In one entry with another drug

Given together, or one or the other

S-1
47
TS-1
14
SOX
6
S1
5
S-1/Cisplatin
4
Nab-paclitaxel and S-1
4
S-1 and Oxaliplatin
3
TS-1® with Cisplatin
3

Studies by the year they started

183 studies that test it; most in 2013 (13)

Studies that test gimeracil, by start year
YearStudies
20011
20021
20043
20057
200612
200711
200811
200910
201010
20119
20129
201313
20147
201511
201611
20178
20185
20199
20205
20214
20224
20235
20244
202510
20263

Who runs them

Industry 25 · Other 158

Taiho Pharmaceutical Co., Ltd. (10) · Fudan University (9) · Taiho Oncology, Inc. (9) · Chinese Academy of Medical Sciences (9) · National Cancer Center, Korea (9) · Kansai Hepatobiliary Oncology Group (6) · Yonsei University (5) · Samsung Medical Center (5)

Often tested with

Tested in the same studies.

Tegafur (183) · Oxonic Acid (181) · Oxaliplatin (48) · Paclitaxel (26) · Gemcitabine (19) · Albumin-Bound Paclitaxel (18) · Cisplatin (17) · Leucovorin (15)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Gimeracil is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 9

Studies that test gimeracil.

Studies

Open first, then newest update. How each study uses gimeracil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 183

See all 183 studies that test gimeracil →

Given beside what is tested · 165 — gimeracil is usual care or a partner of the new treatment

Showing 20 of 165.

As the comparator · 17 — what is tested is compared with gimeracil

Codes

What other systems call gimeracil · ClinicalTrials.gg INT003964

  • MeSH (NLM) C104201gimeracilOne source NLM
  • UNII (FDA) UA8SE1325TGIMERACILConfirmed FDA, NLM, Wikidata
  • Wikidata Q22075887gimeracilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2416GimeracilOne source FDA
  • DrugBank DB09257One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.